• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

开发一种高灵敏度液相色谱-串联质谱法同时测定人血浆中的卢帕他定及其两种活性代谢物:应用于临床药代动力学研究。

Development of a highly sensitive LC-MS/MS method for simultaneous determination of rupatadine and its two active metabolites in human plasma: Application to a clinical pharmacokinetic study.

作者信息

Sun Chenglong, Li Qian, Pan Liping, Liu Bing, Gu Pan, Zhang Junying, Ding Li, Wu Chungyong

机构信息

Department of Pharmaceutical Analysis, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210009, China; Key Laboratory of Drug Quality Control and Pharmacovigilance, Ministry of Education, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210009, China.

Department of Pharmaceutics of Traditional Chinese Medicine, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210009, China.

出版信息

J Pharm Biomed Anal. 2015;111:163-8. doi: 10.1016/j.jpba.2015.03.025. Epub 2015 Apr 3.

DOI:10.1016/j.jpba.2015.03.025
PMID:25890211
Abstract

An easy LC-ESI-MS/MS method was developed and validated for simultaneous determination of rupatadine (RT) and its two active metabolites, namely desloratadine (DT) and 3-hydroxydesloratadine (3-OH-DT), in human plasma. The chromatographic separation was carried out on a C18 column with gradient elution by using methanol and 10mM ammonium acetate containing 0.1% (v/v) formic acid. The lower limit of quantification (LLOQ) was 0.05, 0.035 and 0.035 ng/mL for RT, DT and 3-OH-DT, respectively. The intra- and inter-day precision of analytes were within the range of 1.0-4.7% and 2.2-12.1%, respectively. The intra- and inter-day accuracy of analytes were within the range of -7.7% to 5.2% and -4.1% to 4.8%, respectively. The method was successfully applied to a pharmacokinetic study of RT and its two metabolite DT and 3-OH-DT in healthy volunteers following single (10, 20, 40 mg) and multiple (10 mg) oral doses of rupatadine fumarate tablets.

摘要

建立并验证了一种简便的液相色谱-电喷雾串联质谱(LC-ESI-MS/MS)方法,用于同时测定人血浆中卢帕他定(RT)及其两种活性代谢物,即地氯雷他定(DT)和3-羟基地氯雷他定(3-OH-DT)。采用C18柱,以甲醇和含0.1%(v/v)甲酸的10mM醋酸铵进行梯度洗脱,实现色谱分离。RT、DT和3-OH-DT的定量下限(LLOQ)分别为0.05、0.035和0.035 ng/mL。分析物的日内和日间精密度分别在1.0 - 4.7%和2.2 - 12.1%范围内。分析物的日内和日间准确度分别在-7.7%至5.2%和-4.1%至4.8%范围内。该方法成功应用于健康志愿者单次(10、20、40 mg)和多次(10 mg)口服富马酸卢帕他定片后RT及其两种代谢物DT和3-OH-DT的药代动力学研究。

相似文献

1
Development of a highly sensitive LC-MS/MS method for simultaneous determination of rupatadine and its two active metabolites in human plasma: Application to a clinical pharmacokinetic study.开发一种高灵敏度液相色谱-串联质谱法同时测定人血浆中的卢帕他定及其两种活性代谢物:应用于临床药代动力学研究。
J Pharm Biomed Anal. 2015;111:163-8. doi: 10.1016/j.jpba.2015.03.025. Epub 2015 Apr 3.
2
Simultaneous determination of rupatadine and its metabolite desloratadine in human plasma by a sensitive LC-MS/MS method: application to the pharmacokinetic study in healthy Chinese volunteers.采用灵敏的液相色谱-串联质谱法同时测定人血浆中卢帕他定及其代谢物地氯雷他定:在健康中国志愿者中的药代动力学研究应用
J Pharm Biomed Anal. 2009 Feb 20;49(2):347-53. doi: 10.1016/j.jpba.2008.10.014. Epub 2008 Nov 1.
3
High performance liquid chromatography-tandem mass spectrometric determination of rupatadine in human plasma and its pharmacokinetics.高效液相色谱-串联质谱法测定人血浆中卢帕他定及其药代动力学
J Pharm Biomed Anal. 2008 Aug 5;47(4-5):899-906. doi: 10.1016/j.jpba.2008.03.015. Epub 2008 Mar 26.
4
Simultaneous determination of desloratadine and its active metabolite 3-hydroxydesloratadine in human plasma by LC/MS/MS and its application to pharmacokinetics and bioequivalence.采用液相色谱-串联质谱法同时测定人血浆中地氯雷他定及其活性代谢物3-羟基地氯雷他定,并将其应用于药代动力学和生物等效性研究。
J Pharm Biomed Anal. 2007 Nov 30;45(4):659-66. doi: 10.1016/j.jpba.2007.07.012. Epub 2007 Jul 19.
5
Development and validation of a bioanalytical method for the simultaneous determination of heroin, its main metabolites, naloxone and naltrexone by LC-MS/MS in human plasma samples: Application to a clinical trial of oral administration of a heroin/naloxone formulation.一种用于通过液相色谱-串联质谱法(LC-MS/MS)同时测定人血浆样品中 heroin、其主要代谢物、纳洛酮和纳曲酮的生物分析方法的开发与验证:应用于 heroin/纳洛酮制剂口服给药的临床试验
J Pharm Biomed Anal. 2015 Oct 10;114:105-12. doi: 10.1016/j.jpba.2015.04.044. Epub 2015 May 7.
6
Simultaneous determination of glimepiride and pioglitazone in human plasma by liquid chromatography-tandem mass spectrometry and its application to pharmacokinetic study.采用液相色谱-串联质谱法同时测定人血浆中格列美脲和吡格列酮的浓度及其药代动力学研究。
J Chromatogr B Analyt Technol Biomed Life Sci. 2014 Jun 1;960:247-52. doi: 10.1016/j.jchromb.2014.04.039. Epub 2014 Apr 28.
7
Pharmacokinetic and safety profile of rupatadine when coadministered with azithromycin at steady-state levels: a randomized, open-label, two-way, crossover, Phase I study.卢帕他定与阿奇霉素稳态水平联用时的药代动力学和安全性概况:一项随机、开放标签、双向、交叉的I期研究。
Clin Ther. 2008 Sep;30(9):1639-50. doi: 10.1016/j.clinthera.2008.09.002.
8
LC-MS/MS method for simultaneous determination of valproic acid and major metabolites in human plasma.LC-MS/MS 法同时测定人血浆中丙戊酸及其主要代谢物。
J Chromatogr B Analyt Technol Biomed Life Sci. 2011 Jul 1;879(21):1939-44. doi: 10.1016/j.jchromb.2011.05.022. Epub 2011 May 23.
9
Determination of a potential antitumor quassinoid in rat plasma by UPLC-MS/MS and its application in a pharmacokinetic study.采用超高效液相色谱-串联质谱法测定大鼠血浆中一种潜在的抗肿瘤苦木素类化合物及其在药代动力学研究中的应用。
J Pharm Biomed Anal. 2016 May 30;124:143-148. doi: 10.1016/j.jpba.2016.02.046. Epub 2016 Mar 2.
10
A sensitive LC-MS/MS method for simultaneous determination of R-bambuterol and its active metabolite R-terbutaline in human plasma and urine with application to a clinical pharmacokinetic study.一种灵敏的液相色谱-串联质谱法,用于同时测定人血浆和尿液中的R-班布特罗及其活性代谢物R-特布他林,并应用于一项临床药代动力学研究。
Biomed Chromatogr. 2014 Jul;28(7):994-1002. doi: 10.1002/bmc.3107. Epub 2013 Dec 20.

引用本文的文献

1
New chemometrics-assisted spectrophotometric methods for simultaneous determination of co-formulated drugs montelukast, rupatadine, and desloratadine in their different dosage combinations.新的化学计量学辅助分光光度法同时测定不同剂型组合中共同配制的药物孟鲁司特、卢帕他定和地氯雷他定。
BMC Chem. 2024 Nov 19;18(1):232. doi: 10.1186/s13065-024-01345-6.
2
A single-dose, randomized, open-label, four-period, crossover equivalence trial comparing the clinical similarity of the proposed biosimilar rupatadine fumarate to reference Wystamm in healthy Chinese subjects.一项单剂量、随机、开放标签、四周期、交叉等效性试验,比较拟用生物类似药富马酸卢帕他定与参比制剂Wystamm在健康中国受试者中的临床相似性。
Front Pharmacol. 2024 May 17;15:1328142. doi: 10.3389/fphar.2024.1328142. eCollection 2024.
3
Green quantitative spectrofluorometric analysis of rupatadine and montelukast at nanogram scale using direct and synchronous techniques.采用直接和同步技术对纳克级的卢帕他定和孟鲁司特进行绿色定量荧光光谱分析。
R Soc Open Sci. 2021 Nov 10;8(11):211196. doi: 10.1098/rsos.211196. eCollection 2021 Nov.
4
Route to Prolonged Residence Time at the Histamine H Receptor: Growing from Desloratadine to Rupatadine.延长组胺 H 受体驻留时间的途径:从地氯雷他定到鲁帕他定。
J Med Chem. 2019 Jul 25;62(14):6630-6644. doi: 10.1021/acs.jmedchem.9b00447. Epub 2019 Jul 5.
5
Investigation of the cytotoxicity, apoptosis and pharmacokinetics of Raddeanin A.紫堇灵A的细胞毒性、细胞凋亡及药代动力学研究
Oncol Lett. 2017 Mar;13(3):1365-1369. doi: 10.3892/ol.2017.5588. Epub 2017 Jan 11.
6
Treatment of allergic rhinitis and urticaria: a review of the newest antihistamine drug bilastine.过敏性鼻炎和荨麻疹的治疗:新型抗组胺药物比拉斯汀综述
Ther Clin Risk Manag. 2016 Apr 13;12:585-97. doi: 10.2147/TCRM.S105189. eCollection 2016.